Submitted by dcc on Thu, 2018-04-05 13:39 Study Title: Phase II Study of AZD9291 (Osimertinib) in Advanced NSCLC Patients with Exon 20 Insertion Mutations in EGFRCIRB: Adult CIRB - Early Phase EmphasisLead Group: ECOG-ACRINStatus: ActiveReview Status: Available to Open
